| Company Name: |
TargetMol |
| Tel: |
400-821-0310 15002144251 |
| Email: |
xuexiang.shao@tsbiochem.com |
|
| | Benzoic acid, 4-[2-[(9H-fluoren-9-ylacetyl)amino]ethyl]-, 2-[[2-methoxy-2-[3-(trifluoromethyl)phenyl]ethyl]amino]ethyl ester, (-)- (9CI) Basic information |
| | Benzoic acid, 4-[2-[(9H-fluoren-9-ylacetyl)amino]ethyl]-, 2-[[2-methoxy-2-[3-(trifluoromethyl)phenyl]ethyl]amino]ethyl ester, (-)- (9CI) Chemical Properties |
| Boiling point | 756.1±60.0 °C(Predicted) | | density | 1.234±0.06 g/cm3(Predicted) | | pka | 14.92±0.46(Predicted) |
| | Benzoic acid, 4-[2-[(9H-fluoren-9-ylacetyl)amino]ethyl]-, 2-[[2-methoxy-2-[3-(trifluoromethyl)phenyl]ethyl]amino]ethyl ester, (-)- (9CI) Usage And Synthesis |
| Uses | S-15261 is an orally active and potent anti-hyperglycemic agent. S-15261 reduces hepatic glucose production through direct and insulin-sensitizing effects. S-15261 can be used for the research of insulin resistance syndrome[1][2]. | | References | [1] Caüzac M, et al. S-15261, a new anti-hyperglycemic agent, reduces hepatic glucose production through direct and insulin-sensitizing effects. Biochem Pharmacol. 2005 Aug 15;70(4):527-34. DOI:10.1016/j.bcp.2005.05.020 [2] Marquié G, et al. S15261, a novel agent for the treatment of insulin resistance. Studies on Psammomys obesus. Life Sci. 1997;61(18):1741-53. DOI:10.1016/s0024-3205(97)00798-4 |
| | Benzoic acid, 4-[2-[(9H-fluoren-9-ylacetyl)amino]ethyl]-, 2-[[2-methoxy-2-[3-(trifluoromethyl)phenyl]ethyl]amino]ethyl ester, (-)- (9CI) Preparation Products And Raw materials |
|